Lead Exposure and Prevention Advisory Committee (LEPAC); Notice of Recharter, 10366 [2022-03865]

Download as PDF 10366 Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. The reginfo.gov web link is a United States Government website produced by OMB and the General Services Administration (GSA). Under PRA requirements, OMB’s Office of Information and Regulatory Affairs (OIRA) reviews Federal information collections. jspears on DSK121TN23PROD with NOTICES1 FOR FURTHER INFORMATION CONTACT: Ryan Mehm, Attorney, Bureau of Consumer Protection, (202) 326–2918, Federal Trade Commission, 600 Pennsylvania Ave. NW, Washington, DC 20580. SUPPLEMENTARY INFORMATION: Title: Regulation V, Subpart N (12 CFR 1022.130–1022.138). OMB Control Number: 3084–0128. Type of Review: Extension of a currently approved collection. Annual Burden: After halving the updated estimates to split the PRA burden with the CFPB regarding the Rule, the FTC’s burden totals are 192,722 hours, $4,072,801 in associated labor costs, and $6,227,100 in nonlabor/capital costs. Abstract: The FTC shares enforcement authority with the CFPB for subpart N of Regulation V. Subpart N requires nationwide consumer reporting agencies and nationwide consumer specialty reporting agencies to provide to consumers, upon request, one free file disclosure within any 12-month period. Generally, it requires the nationwide consumer reporting agencies, as defined in Section 603(p) of the Fair Credit Reporting Act (FCRA), 15 U.S.C. 1681a(p), to create and operate a centralized source that provides consumers with the ability to request their free annual file disclosures from each of the nationwide consumer reporting agencies through a centralized internet website, toll-free telephone number, and postal address. Subpart N also requires the nationwide consumer reporting agencies to establish a standardized form for internet and mail requests for annual file disclosures, and provides a model standardized form that may be used to comply with that requirement. It additionally requires nationwide specialty consumer reporting agencies, as defined in Section 603(w) of the FCRA, 15 U.S.C. 1681a(w), to establish a streamlined process for consumers to request annual file disclosures. This streamlined process must include a toll-free telephone number for consumers to make such requests. On November 16, 2021, the FTC sought public comment on the VerDate Sep<11>2014 16:46 Feb 23, 2022 Jkt 256001 information collection requirements associated with the Rule. 86 FR 63387. The Commission received no germane comments. Pursuant to the OMB regulations, 5 CFR part 1320, that implement the PRA, 44 U.S.C. 3501 et seq., the FTC is providing this second opportunity for public comment while seeking OMB approval to renew the preexisting clearance for the Rules. Your comment—including your name and your state—will be placed on the public record of this proceeding. Because your comment will be made public, you are solely responsible for making sure that your comment does not include any sensitive personal information, such as anyone’s Social Security number; date of birth; driver’s license number or other state identification number, or foreign country equivalent; passport number; financial account number; or credit or debit card number. You are also solely responsible for making sure that your comment does not include any sensitive health information, such as medical records or other individually identifiable health information. In addition, your comment should not include any ‘‘trade secret or any commercial or financial information which . . . is privileged or confidential’’—as provided by Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— including in particular competitively sensitive information such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. for a 2-year period through January 17, 2024. FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., MPH, RS, Designated Federal Officer, Branch Chief, National Center for Environmental Health, CDC, 4770 Buford Highway NE, Atlanta, Georgia 30341, telephone (770) 488– 6774; PAllwood@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Josephine Liu, Assistant General Counsel for Legal Counsel. Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22– 009, Research Grants for Preventing Violence and Violence Related Injury (R01), May 10–11, 2022, 8:30 a.m., EDT– 5:30 p.m., EDT, Web Conference, in the original FRN. The meeting was published in the Federal Register on February 14, 2022, Volume 87, Number 30, page(s) 8252. The meeting is being amended to reflect the correct Notice of Funding Opportunity (NOFO) number and should read as follows: CE22–005, Research Grants for Preventing Violence and Violence Related Injury (R01). The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific Review Official, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, Georgia 30341, Telephone (404) 639–6473, AWilkes@ cdc.gov. [FR Doc. 2022–03914 Filed 2–23–22; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Lead Exposure and Prevention Advisory Committee (LEPAC); Notice of Recharter Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of recharter. AGENCY: This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Lead Exposure and Prevention Advisory Committee (LEPAC), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed SUMMARY: PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–03865 Filed 2–23–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22–005, Research Grants for Preventing Violence and Violence Related Injury (R01); Amended Notice of Meeting E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 87, Number 37 (Thursday, February 24, 2022)]
[Notices]
[Page 10366]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03865]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Lead Exposure and Prevention Advisory Committee (LEPAC); Notice 
of Recharter

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of recharter.

-----------------------------------------------------------------------

SUMMARY: This gives notice under the Federal Advisory Committee Act of 
October 6, 1972, that the Lead Exposure and Prevention Advisory 
Committee (LEPAC), Centers for Disease Control and Prevention, 
Department of Health and Human Services, has been renewed for a 2-year 
period through January 17, 2024.

FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., MPH, RS, 
Designated Federal Officer, Branch Chief, National Center for 
Environmental Health, CDC, 4770 Buford Highway NE, Atlanta, Georgia 
30341, telephone (770) 488-6774; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-03865 Filed 2-23-22; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.